Sweden · Delayed Price · Currency is SEK Humana AB Earnings Call Transcripts
Fiscal Year 2026
-
Margins improved to 4.6% on efficiency gains and higher occupancy, despite a SEK 450 million revenue drop from divestments and currency headwinds. Acquisitions and new contracts support a positive outlook, with margin targets expected in 2–3 years.
Fiscal Year 2025
-
Q4 saw strong pipeline growth with SEK 450 million in new projects, a 65% EPS increase, and improved profitability in Norway and Finland. Share buybacks and a higher dividend reflect robust capital allocation, while efficiency programs and digitalization support future margin expansion.
-
All-time high profit and margin achieved, with strong improvements in Finland and Norway and a 32% EPS increase year-over-year. Efficiency programs are delivering savings, and the growth pipeline has tripled, supporting a positive outlook despite some segment-specific challenges.
-
Profitability improved in Sweden and Norway, while Finland remains in transition but is expected to recover in Q3. New contracts, cost-saving programs, and a refinancing deal support a positive outlook, with digital and AI initiatives set to drive future growth.
-
Profitability improved for the fourth consecutive quarter, with adjusted EBIT up 8% year-over-year and strong organic growth in Norway. Divestment in Finland and investments in higher-margin segments support a positive outlook, while cash flow and leverage improved.
Fiscal Year 2024
-
Annual revenue grew 7% to SEK 10.3 billion, with strong cash flow and improved EBIT margin. Completed Finnish elderly care divestment, integrated Team Olivia Norway, and proposed a SEK 1 dividend plus share repurchase. Focus remains on cost control, specialization, and organic growth.
-
Record-high adjusted operating profit and 11% revenue growth were achieved, driven by successful integration of Team Olivia in Norway and strong performance in Sweden and Finland. Ongoing consolidation, cost control, and efficiency projects are expected to further improve margins and stability.
-
Adjusted operating profit rose 40% year-over-year to SEK 107 million, driven by strong improvements in elderly care and strategic actions including acquisitions and divestments. Net revenues grew 5%, with solid cash flow and increased leverage due to acquisitions. Integration and cost adaptation remain key priorities.